James Stanker
Chief Financial Officer
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Financial Officer | $160,200 | $342,624 |
| 2022 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Financial Officer | $93,875 | $1,040,278 |
| 2021 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Financial Officer | $87,500 | $434,512 |
| 2020 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Financial Officer | $87,500 | $467,552 |
| 2019 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Financial Officer | $87,500 | $250,702 |
Executive changes
Earnings-call appearances
-
Processa Pharmaceuticals, Inc. Q2 FY2022 Earnings Call2022-08-12
Processa Pharmaceuticals, Inc. (PCSA)
-
Processa Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-08-13
Processa Pharmaceuticals, Inc. (PCSA)